Xenon showcases new long-term azetukalner data from x-tole ole study in fos at aes 2024

– ole data shows sustained monthly reduction in seizure frequency, impressive seizure freedom rates, and consistent ae safety profile suggesting long-term efficacy and tolerability of azetukalner

AES Ratings Summary

AES Quant Ranking